Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Haffmans

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
General Pharmacology|January 1, 1987
Inhibition of enkephalinase activity attenuates naloxone-precipitated withdrawal symptomsJ Haffmans, M R Dzoljic
Journal of Neural Transmission|January 1, 1983
Differential epileptogenic potentials of selective mu and delta opiate receptor agonistsJ Haffmans, M R Dzoljic
International Clinical Psychopharmacology|July 1, 1989
Treatment of resistant depression. Review on the efficacy of various biological treatments, specifically in major depression resistant to cyclic antidepressantsW A Nolen, J Haffmans
Pharmacology|January 1, 1987
Effects of delta opioid antagonists on enkephalin-induced seizuresJ Haffmans, M R Dzoljic
The Journal of Clinical Psychiatry|October 15, 1998
Suicide after bright light treatment in seasonal affective disorder: a case reportJ Haffmans, S Lucius, N Ham
The British Journal of Psychiatry : the Journal of Mental Science|March 1, 1992
Lowest effective dose of depot neurolepticsE Hoencamp, P J Haffmans, G S Jansen
Brain Research|June 4, 1984
Metabolic rate in different rat brain areas during seizures induced by a specific delta opiate receptor agonistJ Haffmans, R De Kloet, M R Dzoljic
Neuropharmacology|April 1, 1986
Regional cerebral blood flow during enkephalin-induced seizures in the ratJ Haffmans, J Heiligers, M R Dzoljic, et al.
Journal of Clinical Psychopharmacology|September 23, 2000
Lithium augmentation of venlafaxine: an open-label trialE Hoencamp, J Haffmans, W A Dijken, et al.
Neuroscience|July 1, 1987
Phelorphan, an inhibitor of enzymes involved in the biodegradation of enkephalins, affected the withdrawal symptoms in chronic morphine-dependent ratsJ Haffmans, M V Walsum, J C van Amsterdam, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
General Pharmacology|January 1, 1987
Inhibition of enkephalinase activity attenuates naloxone-precipitated withdrawal symptomsJ Haffmans, M R Dzoljic
Journal of Neural Transmission|January 1, 1983
Differential epileptogenic potentials of selective mu and delta opiate receptor agonistsJ Haffmans, M R Dzoljic
International Clinical Psychopharmacology|July 1, 1989
Treatment of resistant depression. Review on the efficacy of various biological treatments, specifically in major depression resistant to cyclic antidepressantsW A Nolen, J Haffmans
Pharmacology|January 1, 1987
Effects of delta opioid antagonists on enkephalin-induced seizuresJ Haffmans, M R Dzoljic
The Journal of Clinical Psychiatry|October 15, 1998
Suicide after bright light treatment in seasonal affective disorder: a case reportJ Haffmans, S Lucius, N Ham
The British Journal of Psychiatry : the Journal of Mental Science|March 1, 1992
Lowest effective dose of depot neurolepticsE Hoencamp, P J Haffmans, G S Jansen
Brain Research|June 4, 1984
Metabolic rate in different rat brain areas during seizures induced by a specific delta opiate receptor agonistJ Haffmans, R De Kloet, M R Dzoljic
Neuropharmacology|April 1, 1986
Regional cerebral blood flow during enkephalin-induced seizures in the ratJ Haffmans, J Heiligers, M R Dzoljic, et al.
Journal of Clinical Psychopharmacology|September 23, 2000
Lithium augmentation of venlafaxine: an open-label trialE Hoencamp, J Haffmans, W A Dijken, et al.
Neuroscience|July 1, 1987
Phelorphan, an inhibitor of enzymes involved in the biodegradation of enkephalins, affected the withdrawal symptoms in chronic morphine-dependent ratsJ Haffmans, M V Walsum, J C van Amsterdam, et al.
Pageof 2